Published in J Biol Chem on January 26, 1996
The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies. Blood (2010) 1.11
Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model. Thromb Haemost (2008) 1.09
Lytic resistance of fibrin containing red blood cells. Arterioscler Thromb Vasc Biol (2011) 0.96
Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery. J Anesth (2009) 0.96
Clot retraction affects the extent of ultrasound-enhanced thrombolysis in an ex vivo porcine thrombosis model. Ultrasound Med Biol (2013) 0.94
Engineering fibrin polymers through engagement of alternative polymerization mechanisms. Biomaterials (2011) 0.87
The spatial dynamics of fibrin clot dissolution catalyzed by erythrocyte-bound vs. free fibrinolytics. J Thromb Haemost (2010) 0.87
Plasminogen on the surfaces of fibrin clots prevents adhesion of leukocytes and platelets. J Thromb Haemost (2009) 0.87
Fibrinolytic effects of Ginkgo biloba extract. Exp Clin Cardiol (2005) 0.80
S-nitrosoglutathione acts as a small molecule modulator of human fibrin clot architecture. PLoS One (2012) 0.79
Highly effective fibrinolysis by a sequential synergistic combination of mini-dose tPA plus low-dose mutant proUK. PLoS One (2015) 0.79
Cl- and F- anions regulate the architecture of protofibrils in fibrin gel. Eur Biophys J (2009) 0.77
Fibrinogen counteracts the antiadhesive effect of fibrin-bound plasminogen by preventing its activation by adherent U937 monocytic cells. J Thromb Haemost (2012) 0.77
Towards a multi-physics modelling framework for thrombolysis under the influence of blood flow. J R Soc Interface (2015) 0.76
Fibrin-specific and effective clot lysis requires both plasminogen activators and for them to be in a sequential rather than simultaneous combination. J Thromb Thrombolysis (2017) 0.75
Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts. PLoS One (2017) 0.75
Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem (1982) 3.95
Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem (1981) 2.80
In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells. J Biol Chem (1983) 2.61
Endoplasmic reticulum chaperones GRP78 and calreticulin prevent oxidative stress, Ca2+ disturbances, and cell death in renal epithelial cells. J Biol Chem (1997) 2.16
Relationship between tissue plasminogen activator and the activators in blood and vascular wall. Thromb Res (1980) 1.76
Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus. Nature (1981) 1.45
Purification and partial characterization of plasminogen activator from human uterine tissue. Biochim Biophys Acta (1979) 1.38
Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J Pharmacol Exp Ther (1997) 1.37
Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. J Biol Chem (1982) 1.35
Acceleration of fibrinolysis by high-frequency ultrasound: the contribution of acoustic streaming and temperature rise. Thromb Res (2000) 1.35
Superficial accumulation of plasminogen during plasma clot lysis. Circulation (1995) 1.30
The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest (1985) 1.22
Quantitation of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay. Thromb Res (1984) 1.18
Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1). Thromb Haemost (1988) 1.17
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro. Thromb Haemost (1981) 1.17
Immunological characterization of plasminogen activator activities in human tissues and body fluids. J Lab Clin Med (1981) 1.17
Dephosphorylation of focal adhesion kinase (FAK) and loss of focal contacts precede caspase-mediated cleavage of FAK during apoptosis in renal epithelial cells. J Biol Chem (1999) 1.16
Production of plasminogen activators and inhibitor by serially propagated endothelial cells from adult human blood vessels. Arteriosclerosis (1987) 1.16
Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells. J Biol Chem (1988) 1.12
Binding of tissue-type plasminogen activator by the mannose receptor. J Biol Chem (1991) 1.10
Natural killer cells infiltrating colorectal cancer and MHC class I expression. Mol Immunol (2005) 1.08
Processing of acetylated human low-density lipoprotein by parenchymal and non-parenchymal liver cells. Involvement of calmodulin? Biochem J (1982) 1.03
The effect of flow on lysis of plasma clots in a plasma environment. Thromb Haemost (2000) 1.01
Caspase-3 activity as a prognostic factor in colorectal carcinoma. Lab Invest (2001) 1.01
Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjects. Clin Pharmacol Ther (1989) 1.00
Cisplatin effects on F-actin and matrix proteins precede renal tubular cell detachment and apoptosis in vitro. Cell Death Differ (1998) 1.00
Role of mitochondrial Ca2+ in the oxidative stress-induced dissipation of the mitochondrial membrane potential. Studies in isolated proximal tubular cells using the nephrotoxin 1,2-dichlorovinyl-L-cysteine. J Biol Chem (1994) 1.00
Hepatic processing of the cholesteryl ester from low density lipoprotein in the rat. J Biol Chem (1986) 0.99
The effect of Ca2+ and the trifluoperazine on the processing of human acetylated low density lipoprotein by non-parenchymal liver cells. FEBS Lett (1981) 0.99
The effect of a water-soluble tris-galactoside-terminated cholesterol derivative on the fate of low density lipoproteins and liposomes. J Biol Chem (1985) 0.98
Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay. J Lab Clin Med (1983) 0.96
On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B. J Biol Chem (1997) 0.95
The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor. J Thromb Haemost (2005) 0.94
Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells. Biochem J (1987) 0.94
Monoclonal antibodies against the human mannose receptor as a specific marker in flow cytometry and immunohistochemistry for macrophages. J Leukoc Biol (1997) 0.93
The amount of plasminogen, tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in human thrombi and the relation to ex-vivo lysibility. Thromb Haemost (1992) 0.93
Prevention of cycloheximide-induced apoptosis in hepatocytes by adenosine and by caspase inhibitors. Biochem Pharmacol (1999) 0.93
Clearance of the heavy and light polypeptide chains of human tissue-type plasminogen activator in rats. Biochem J (1986) 0.92
In vivo catabolism of biologically modified LDL. Arteriosclerosis (1984) 0.92
Pharmacokinetics of antigen and activity of recombinant tissue-type plasminogen activator after infusion in healthy volunteers. Arzneimittelforschung (1988) 0.91
F-actin disorganization in apoptotic cell death of cultured rat renal proximal tubular cells. Am J Physiol (1996) 0.90
High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke. J Thromb Haemost (2005) 0.90
Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivo. Thromb Haemost (1982) 0.90
The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study. J Thromb Haemost (2009) 0.90
In vivo uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial, and parenchymal cells. J Pharm Sci (1984) 0.89
Visualization of the interaction of native and modified low density lipoproteins with isolated rat liver cells. Eur J Cell Biol (1985) 0.89
Analytical study of microsomes and isolated subcellular membranes from rat liver. IX. Nicotinamide adenine dinucleotide glycohydrolase: a plasma membrane enzyme prominently found in Kupffer cells. J Cell Biol (1985) 0.89
The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. J Clin Endocrinol Metab (2012) 0.89
Lysine-based cluster mannosides that inhibit ligand binding to the human mannose receptor at nanomolar concentration. J Biol Chem (1996) 0.88
Quantification and visualization of the transport of octreotide, a somatostatin analogue, across monolayers of cerebrovascular endothelial cells. Pharm Res (1994) 0.87
Role of NK cells in adoptive immunotherapy of metastatic colorectal cancer in a syngeneic rat model. Immunol Rev (2001) 0.86
Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol. Thromb Haemost (1984) 0.86
Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity. Science (1987) 0.86
Inhibition of the oxidative metabolism of theophylline in isolated rat hepatocytes by the quinolone antibiotic enoxacin and its metabolite oxoenoxacin, but not by ofloxacin. Biochem Pharmacol (1988) 0.86
Diffusion rates and transport pathways of fluorescein isothiocyanate (FITC)-labeled model compounds through buccal epithelium. Pharm Res (1994) 0.85
Evaluation of nephrotoxicity in vitro using a suspension of highly purified porcine proximal tubular cells and characterization of the cells in primary culture. Exp Nephrol (1995) 0.85
Extracellular adenosine-induced apoptosis in mouse neuroblastoma cells: studies on involvement of adenosine receptors and adenosine uptake. Biochem Pharmacol (2001) 0.85
Interaction of mutants of tissue-type plasminogen activator with liver cells: effect of domain deletions. Biochem J (1996) 0.85
Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children. J Thromb Haemost (2007) 0.85
Fibrinolytic properties of activated FXII. Eur J Biochem (1999) 0.85
Alkylation-induced oxidative cell injury of renal proximal tubular cells: involvement of glutathione redox-cycle inhibition. Arch Biochem Biophys (1996) 0.85
In vivo and in vitro catabolism of native and biologically modified LDL. FEBS Lett (1984) 0.84
Processing of cholesteryl ester from low-density lipoproteins in the rat. Hepatic metabolism and biliary secretion after uptake by different hepatic cell types. Biochem J (1989) 0.84
Isolation and functional characterization of the heavy and light chains of human tissue-type plasminogen activator. J Biol Chem (1986) 0.84
Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator. Circulation (1997) 0.84
Effects of N-trimethyl chitosan chloride, a novel absorption enhancer, on caco-2 intestinal epithelia and the ciliary beat frequency of chicken embryo trachea. Int J Pharm (1999) 0.83
Induction of apoptosis and changes in nuclear G-actin are mediated by different pathways: the effect of inhibitors of protein and RNA synthesis in isolated rat hepatocytes. Toxicol Appl Pharmacol (1999) 0.83
Mechanisms of plasminogen activation. J Intern Med (1994) 0.83
Involvement of intracellular Ca2+ and K+ in dissipation of the mitochondrial membrane potential and cell death induced by extracellular ATP in hepatocytes. Biochem J (1992) 0.83
Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro. Thromb Haemost (1999) 0.82
Binding of the radioligand [35S]adenosine 5'-O-(2-thiodiphosphate) and intracellular calcium response in rat liver parenchymal cells. Biochem Pharmacol (1993) 0.82
Increased plasminogen activator inhibition levels in malignancy. Thromb Haemost (1987) 0.82
Calcium-induced cytotoxicity in hepatocytes after exposure to extracellular ATP is dependent on inorganic phosphate. Effects on mitochondrial calcium. J Biol Chem (1993) 0.82
Complexes between tissue-type plasminogen activator and proteinase inhibitors in human plasma, identified with an immunoradiometric assay. J Lab Clin Med (1983) 0.82
Monoclonal antibodies against the human mannose receptor that inhibit the binding of tissue-type plasminogen activator. Thromb Haemost (1997) 0.81
Activation of thrombin-inactivated single-chain urokinase-type plasminogen activator by dipeptidyl peptidase I (cathepsin C). Eur J Biochem (1994) 0.81
A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluids. Thromb Haemost (1996) 0.81
Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture. Thromb Haemost (1981) 0.81
Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasminogen activator and its specific inhibitor. Eur J Clin Invest (1985) 0.80
Renal proximal tubular cells in suspension or in primary culture as in vitro models to study nephrotoxicity. Chem Biol Interact (1990) 0.80
Rapid transport of fatty acids from rat liver endothelial to parenchymal cells after uptake of cholesteryl ester-labeled acetylated LDL. Biochim Biophys Acta (1986) 0.80
On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction. Acta Med Scand (1987) 0.80
Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA. Biochem J (1992) 0.80
Composition and susceptibility to thrombolysis of pathological human arterial thrombi. Ann N Y Acad Sci (1992) 0.80
Isolation and characterization of the mannose receptor from human liver potentially involved in the plasma clearance of tissue-type plasminogen activator. Hepatology (1992) 0.80
Specific fibrinolytic properties of different molecular forms of pro-urokinase from a monkey kidney cell culture. Thromb Res (1986) 0.80
The role of a purinergic P2z receptor in calcium-dependent cell killing of isolated rat hepatocytes by extracellular adenosine triphosphate. Hepatology (1996) 0.80
Binding of carboxypeptidase N to fibrinogen and fibrin. Biochem Biophys Res Commun (2012) 0.79
Isolation of parenchymal cell-derived particles from non-parenchymal rat liver cell preparations. Exp Cell Res (1982) 0.79
Binding of tissue-type plasminogen activator to fibrinogen fragments. Eur J Biochem (1988) 0.79
Polylysine as a vehicle for extracellular matrix-targeted local drug delivery, providing high accumulation and long-term retention within the vascular wall. Arterioscler Thromb Vasc Biol (2001) 0.79
Inhibition of succinate:ubiquinone reductase and decrease of ubiquinol in nephrotoxic cysteine S-conjugate-induced oxidative cell injury. Mol Pharmacol (1995) 0.79
Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin. J Clin Invest (1991) 0.79
The effect of methylated beta-cyclodextrins on the tight junctions of the rat nasal respiratory epithelium: electron microscopic and confocal laser scanning microscopic visualization studies. J Control Release (1999) 0.79
alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder. J Clin Invest (1987) 0.79
Urokinase-mediated fibrinolysis in the synovial fluid of rheumatoid arthritis patients may be affected by the inactivation of single chain urokinase type plasminogen activator by thrombin. Ann Rheum Dis (2000) 0.79
Characterization of a plasminogen activator secreted by cultured bovine aortic endothelial cells. Biochim Biophys Acta (1982) 0.78
Changes of G-actin localisation in the mitotic spindle region or nucleus during mitosis and after heat shock: a histochemical study of G-actin in various cell lines with fluorescent labelled vitamin D-binding protein. Biochim Biophys Acta (1999) 0.78
In vivo and in vitro interaction of high and low molecular weight single-chain urokinase-type plasminogen activator with rat liver cells. J Biol Chem (1992) 0.78